|
WO2013066438A2
(en)
|
2011-07-22 |
2013-05-10 |
President And Fellows Of Harvard College |
Evaluation and improvement of nuclease cleavage specificity
|
|
US10704021B2
(en)
|
2012-03-15 |
2020-07-07 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US9163284B2
(en)
|
2013-08-09 |
2015-10-20 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a Cas9 nuclease
|
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
|
US9322037B2
(en)
|
2013-09-06 |
2016-04-26 |
President And Fellows Of Harvard College |
Cas9-FokI fusion proteins and uses thereof
|
|
US9526784B2
(en)
|
2013-09-06 |
2016-12-27 |
President And Fellows Of Harvard College |
Delivery system for functional nucleases
|
|
US9340799B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
MRNA-sensing switchable gRNAs
|
|
US20150166984A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting alpha-antitrypsin point mutations
|
|
CN105939767B
(zh)
|
2014-01-08 |
2018-04-06 |
弗洛设计声能学公司 |
具有双声电泳腔的声电泳装置
|
|
AU2015298571B2
(en)
|
2014-07-30 |
2020-09-03 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
|
US12129471B2
(en)
|
2015-02-23 |
2024-10-29 |
Vertex Pharmaceuticals Incorporated |
Materials and methods for treatment of human genetic diseases including hemoglobinopathies
|
|
WO2016135558A2
(en)
|
2015-02-23 |
2016-09-01 |
Crispr Therapeutics Ag |
Materials and methods for treatment of hemoglobinopathies
|
|
US11708572B2
(en)
|
2015-04-29 |
2023-07-25 |
Flodesign Sonics, Inc. |
Acoustic cell separation techniques and processes
|
|
US11377651B2
(en)
|
2016-10-19 |
2022-07-05 |
Flodesign Sonics, Inc. |
Cell therapy processes utilizing acoustophoresis
|
|
EP3763814A1
(en)
*
|
2015-05-08 |
2021-01-13 |
The Children's Medical Center Corporation |
Targeting bcl11a enhancer functional regions for fetal hemoglobin reinduction
|
|
CA2986310A1
(en)
|
2015-05-11 |
2016-11-17 |
Editas Medicine, Inc. |
Optimized crispr/cas9 systems and methods for gene editing in stem cells
|
|
SG10202112057QA
(en)
|
2015-05-12 |
2021-12-30 |
Sangamo Therapeutics Inc |
Nuclease-mediated regulation of gene expression
|
|
US11911415B2
(en)
|
2015-06-09 |
2024-02-27 |
Editas Medicine, Inc. |
CRISPR/Cas-related methods and compositions for improving transplantation
|
|
WO2017070632A2
(en)
|
2015-10-23 |
2017-04-27 |
President And Fellows Of Harvard College |
Nucleobase editors and uses thereof
|
|
EP3371306B8
(en)
|
2015-11-04 |
2023-02-22 |
Vertex Pharmaceuticals Incorporated |
Materials and methods for treatment of hemoglobinopathies
|
|
US11214789B2
(en)
|
2016-05-03 |
2022-01-04 |
Flodesign Sonics, Inc. |
Concentration and washing of particles with acoustics
|
|
WO2018027078A1
(en)
|
2016-08-03 |
2018-02-08 |
President And Fellows Of Harard College |
Adenosine nucleobase editors and uses thereof
|
|
AU2017308889B2
(en)
|
2016-08-09 |
2023-11-09 |
President And Fellows Of Harvard College |
Programmable Cas9-recombinase fusion proteins and uses thereof
|
|
WO2018039438A1
(en)
|
2016-08-24 |
2018-03-01 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
|
WO2018064387A1
(en)
|
2016-09-28 |
2018-04-05 |
Novartis Ag |
Porous membrane-based macromolecule delivery system
|
|
KR20240007715A
(ko)
|
2016-10-14 |
2024-01-16 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵염기 에디터의 aav 전달
|
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
|
TW201839136A
(zh)
|
2017-02-06 |
2018-11-01 |
瑞士商諾華公司 |
治療血色素異常症之組合物及方法
|
|
KR20190123328A
(ko)
|
2017-03-09 |
2019-10-31 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
암 백신
|
|
WO2018165504A1
(en)
|
2017-03-09 |
2018-09-13 |
President And Fellows Of Harvard College |
Suppression of pain by gene editing
|
|
CN110914310A
(zh)
|
2017-03-10 |
2020-03-24 |
哈佛大学的校长及成员们 |
胞嘧啶至鸟嘌呤碱基编辑器
|
|
EP3596217A1
(en)
|
2017-03-14 |
2020-01-22 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
|
IL306092A
(en)
|
2017-03-23 |
2023-11-01 |
Harvard College |
Nucleic base editors that include nucleic acid programmable DNA binding proteins
|
|
EP3606341A4
(en)
|
2017-04-04 |
2021-04-21 |
The Board of Trustees of the Leland Stanford Junior University |
PREPARATION, EXPANSION AND USES OF ADULT PLURIPOTENT STEM CELLS
|
|
US12110499B2
(en)
|
2017-04-24 |
2024-10-08 |
Seattle Children's Hospital |
Homology directed repair compositions for the treatment of hemoglobinopathies
|
|
EP3622070A2
(en)
*
|
2017-05-10 |
2020-03-18 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease systems and methods
|
|
US11560566B2
(en)
|
2017-05-12 |
2023-01-24 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
|
|
US11788087B2
(en)
*
|
2017-05-25 |
2023-10-17 |
The Children's Medical Center Corporation |
BCL11A guide delivery
|
|
US20200140896A1
(en)
|
2017-06-30 |
2020-05-07 |
Novartis Ag |
Methods for the treatment of disease with gene editing systems
|
|
EP3652312A1
(en)
|
2017-07-14 |
2020-05-20 |
Editas Medicine, Inc. |
Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
|
|
EP3658573A1
(en)
|
2017-07-28 |
2020-06-03 |
President and Fellows of Harvard College |
Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace)
|
|
EP3676376B1
(en)
|
2017-08-30 |
2025-01-15 |
President and Fellows of Harvard College |
High efficiency base editors comprising gam
|
|
CA3077391A1
(en)
*
|
2017-09-29 |
2019-04-04 |
Intellia Therapeutics, Inc. |
In vitro method of mrna delivery using lipid nanoparticles
|
|
CN109706148A
(zh)
*
|
2017-09-30 |
2019-05-03 |
广东赤萌医疗科技有限公司 |
一种用于敲除BCL11A基因或者BCL11A基因增强子的gRNA、gRNA组合物以及电转方法
|
|
CA3082251A1
(en)
|
2017-10-16 |
2019-04-25 |
The Broad Institute, Inc. |
Uses of adenosine base editors
|
|
MA50849A
(fr)
*
|
2017-10-26 |
2020-09-02 |
Vertex Pharma |
Substances et procédés pour le traitement d'hémoglobinopathies
|
|
CN109722414A
(zh)
*
|
2017-10-27 |
2019-05-07 |
博雅辑因（北京）生物科技有限公司 |
一种高效制备成熟红细胞的方法以及用于制备成熟红细胞的培养基
|
|
EP3704245A1
(en)
|
2017-11-01 |
2020-09-09 |
Novartis AG |
Synthetic rnas and methods of use
|
|
SG11202004529XA
(en)
*
|
2017-11-16 |
2020-06-29 |
Mogam Inst Biomedical Res |
Transformed human cell and use thereof
|
|
WO2019106522A1
(en)
*
|
2017-11-28 |
2019-06-06 |
Novartis Ag |
Pooled crispr/cas9 screening in primary cells using guide swap technology
|
|
JP2021505587A
(ja)
*
|
2017-12-05 |
2021-02-18 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
Ｃｒｉｓｐｒ−ｃａｓ９改変ｃｄ３４＋ヒト造血幹・前駆細胞及びその使用
|
|
CN114900773A
(zh)
|
2017-12-14 |
2022-08-12 |
弗洛设计声能学公司 |
声泳系统及其操作方法、控制声换能器及声学系统的方法
|
|
US12406749B2
(en)
|
2017-12-15 |
2025-09-02 |
The Broad Institute, Inc. |
Systems and methods for predicting repair outcomes in genetic engineering
|
|
EP3735412B1
(en)
*
|
2018-01-03 |
2024-02-21 |
EdiGene Biotechnology, Inc. |
Compositions and methods for the expansion of hematopoietic stem and progenitor cells and treatment of inherited metabolic disorders
|
|
EP3743516A4
(en)
*
|
2018-01-26 |
2021-10-13 |
The Children's Medical Center Corporation |
TARGETING OF DISTAL BCL11A REGULATORY ELEMENTS WITH A CAS9-CAS9 FUSION TO REDUCE FETAL HEMOGLOBIN
|
|
MA51787A
(fr)
*
|
2018-02-05 |
2020-12-16 |
Vertex Pharma |
Substances et méthodes de traitement d'hémoglobinopathies
|
|
EP3749768A1
(en)
*
|
2018-02-05 |
2020-12-16 |
Vertex Pharmaceuticals Incorporated |
Materials and methods for treatment of hemoglobinopathies
|
|
IL277234B2
(en)
|
2018-03-14 |
2026-03-01 |
Editas Medicine Inc |
Systems and methods for treating hemoglobin diseases
|
|
US12522811B2
(en)
*
|
2018-05-01 |
2026-01-13 |
The Children's Medical Center Corporation |
Enhanced BCL11A RNP / CRISPR delivery and editing using a 3XNLS-CAS9
|
|
US12350284B2
(en)
|
2018-05-02 |
2025-07-08 |
The Children's Medical Center Corporation |
BCL11A microRNAs for treating hemoglobinopathies
|
|
CN112105732A
(zh)
*
|
2018-05-10 |
2020-12-18 |
先正达参股股份有限公司 |
用于多核苷酸的靶向编辑的方法和组合物
|
|
CN112654710A
(zh)
|
2018-05-16 |
2021-04-13 |
辛瑟高公司 |
用于指导rna设计和使用的方法和系统
|
|
WO2019226953A1
(en)
|
2018-05-23 |
2019-11-28 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
|
EP3820495A4
(en)
|
2018-07-09 |
2022-07-20 |
The Broad Institute Inc. |
RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES
|
|
CA3113255A1
(en)
*
|
2018-09-21 |
2020-03-26 |
APstem Therapeutics, Inc. |
Human pluripotent adult stem cells
|
|
WO2020092453A1
(en)
|
2018-10-29 |
2020-05-07 |
The Broad Institute, Inc. |
Nucleobase editors comprising geocas9 and uses thereof
|
|
EP3887521A1
(en)
*
|
2018-11-29 |
2021-10-06 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
|
US12351837B2
(en)
|
2019-01-23 |
2025-07-08 |
The Broad Institute, Inc. |
Supernegatively charged proteins and uses thereof
|
|
WO2020191241A1
(en)
|
2019-03-19 |
2020-09-24 |
The Broad Institute, Inc. |
Methods and compositions for editing nucleotide sequences
|
|
WO2020214842A1
(en)
|
2019-04-17 |
2020-10-22 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
CN111939271A
(zh)
*
|
2019-04-30 |
2020-11-17 |
博雅辑因（北京）生物科技有限公司 |
一种血红蛋白病治疗有效性预测方法
|
|
CA3138029A1
(en)
*
|
2019-04-30 |
2020-11-05 |
Edigene Inc. |
Method for predicting effectiveness of treatment of hemoglobinopathy
|
|
EP3990650A4
(en)
*
|
2019-06-28 |
2024-03-20 |
ASC Therapeutics Inc. |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF THALASSEMIA OR SICKLE CELL DISEASE
|
|
CN114364799B
(zh)
*
|
2019-08-28 |
2024-07-19 |
甘李药业股份有限公司 |
编辑造血干/祖细胞中bcl11a基因的方法
|
|
US20220380757A1
(en)
*
|
2019-09-30 |
2022-12-01 |
The Children's Medical Center Corporation |
Bcl11a guide and base editor delivery
|
|
US12435330B2
(en)
|
2019-10-10 |
2025-10-07 |
The Broad Institute, Inc. |
Methods and compositions for prime editing RNA
|
|
CA3177481A1
(en)
|
2020-05-08 |
2021-11-11 |
David R. Liu |
Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
|
|
CN114149990A
(zh)
*
|
2020-09-08 |
2022-03-08 |
甘李药业股份有限公司 |
编辑造血干/祖细胞中bcl11a基因的方法
|
|
US12079386B2
(en)
|
2020-09-14 |
2024-09-03 |
Zebra Technologies Corporation |
Devices having protective screens selectively positionable to switch devices between user interface modes and methods of operating the same
|
|
EP4255502A4
(en)
*
|
2020-12-03 |
2025-07-16 |
Scribe Therapeutics Inc |
COMPOSITIONS AND METHODS FOR TARGETING BCL11A
|
|
EP4314308A4
(en)
*
|
2021-04-02 |
2026-05-20 |
Univ Shanghai Technology |
GENE THERAPY FOR THE TREATMENT OF BETA-HEMOGLOBINOPATHIES
|
|
WO2022240787A1
(en)
*
|
2021-05-13 |
2022-11-17 |
The Children's Medical Center Corporation |
Methods for stratifying subjects for fetal hemoglobin reinduction
|
|
CN113584167B
(zh)
*
|
2021-07-07 |
2023-10-03 |
武汉大学中南医院 |
一种用于检测FLT3-F691L突变的crRNA、等温扩增引物和试剂盒
|
|
EP4273242A1
(en)
*
|
2022-05-03 |
2023-11-08 |
ETH Zurich |
Crispr-based modification of human hbd gene
|
|
WO2023214512A1
(ja)
|
2022-05-06 |
2023-11-09 |
学校法人常翔学園 |
人工ｒｎａ分子
|
|
JP2025526403A
(ja)
*
|
2022-07-25 |
2025-08-13 |
セリントラ・セラピューティクス・エスア |
ゲノム編集のための組成物及び方法
|
|
US20240229021A9
(en)
*
|
2022-10-21 |
2024-07-11 |
Georgia Tech Research Corporation |
Transcriptional programming in a bacteroides consortium
|
|
CN116445402B
(zh)
*
|
2023-05-09 |
2025-04-25 |
中国科学院生态环境研究中心 |
红系祖细胞的扩增培养基、扩增培养方法及应用
|
|
WO2025128871A2
(en)
|
2023-12-13 |
2025-06-19 |
Renagade Therapeutics Management Inc. |
Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
|
|
WO2025174765A1
(en)
|
2024-02-12 |
2025-08-21 |
Renagade Therapeutics Management Inc. |
Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
|